InvestorsHub Logo
Followers 0
Posts 749
Boards Moderated 0
Alias Born 09/14/2017

Re: WeeZuhl post# 35427

Tuesday, 06/26/2018 4:20:14 PM

Tuesday, June 26, 2018 4:20:14 PM

Post# of 38634

The PR announcing Fast Track designation for PODRAS is dated May 26, 2015. More than 3 years ago. In more than 3 years, this super awesome global game changing pure gold everybody will want this for every drug technology has not been advanced ***AT ALL***. In more than 3 years, no partners. In more than 3 years, no proof of concept studies. In more than 3 years, no bioequivalence studies. Exactly how game changing can it be if, in more than 3 years, there hasn't been one single positive step in development. It's not like they were too busy doing HAL studies. Let's just say it is highly unlikely that the shareholder vote scheduled 41 days before NASDAQ delisting has anything to do with PODRAS. I know this because I know PODRAS is a grift. Even if it works as intended, which it won't, it doesn't prevent abuse and doesn't prevent suicide. At best, PODRAS is a very expensive, very finicky replacement for a 5 cent childproof cap. Let's all hope that whatever is up their sleeve, it is way more developed and way more real than PODRAS. 100% Vaporware.



You are completely write - but. Don't forget what has happened around it.

Three years ago Purdue was not as deep in trouble as it is now. They *need* some news to keep selling Oxy. If they can't find it, the losses for Purdue can be counted in billions. I think they already see decreasing sales and it can be worse.

There is still an other thing too. Podras does not need to prevent suicide. Actually nothing can do this. It's quite much enough if it reduces effect of two tablets to effect of 1½ conventional tablets. That's because *none* drug abuser wants to have a drug if it does not have full effect. They do not want to pay price of two tablets and only get effect of 1½ tablets if they want to abuse it.